Worried about your symptoms?
Start the Acute Glaucoma Attack test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Patchy blind spots in vision
Frequent headaches
Halos or colored rings around lights
My eye hurts
Eye pain
Vision loss
I can't see one eye
Blurry vision
Eye redness
Intensely red eye
Tearing from one eye
Eye problems
Not seeing your symptoms? No worries!
A condition caused by high pressures in the eyeball, more common in people with farsightedness. Persons of Black, Asian, or Hispanic descent are at higher risk. The high pressures can cut off blood flow to the eye. Prompt medical attention is needed to prevent permanent blindness.
Your doctor may ask these questions to check for this disease:
This requires emergency medical care. Avoid staying in a dark room or lying down as this can worsen the condition. In the first stage, medicines to lower eye pressures will be given in the form of eyedrops, oral medicine, and medicine given through a needle in the vein. In the second stage, a laser procedure or surgery may be needed to permanently fix the problem.
Reviewed By:
Maxwell J. Nanes, DO (Emergency Medicine)
Dr Nanes received a doctorate from the Chicago College of Osteopathic Medicine and went on to complete a residency in emergency medicine at the Medical College of Wisconsin. There he trained at Froedtert Hospital and Children's Hospital of Wisconsin in the practice of adult and pediatric emergency medicine. He was a chief resident and received numerous awards for teaching excellence during his time there. | | After residency he took a job at a community hospital where he and his colleagues worked through the toughest days of the COVID-19 pandemic. |
Masashi Mimura, MD (Ophthalmology)
Dr. Mimura Graduated from the Osaka Medical College and obtained his ophthalmologist certification in 2007. He opened an outpatient clinic for oculoplastic and reconstructive surgery at Osaka Kaijo Hospital. Subsequently, he was appointed as the assistant professor at the Department of Ophthalmology, Osaka Medical College, in 2014. He then served an international fellowship at the Department of Ophthalmology/Oculoplastic and Reconstructive Surgery, California State University, San Diego. Since then, he has been appointed as Lecturer in the Departments of Ophthalmology at Osaka Medical College and Toho University Medical Center Sakura Hospital. Dr. Mimura is currently the Director of Oculofacial Clinic Osaka, where he specializes in Oculofacial Plastic and Reconstructive Surgery.
Content updated on Feb 19, 2025
Following the Medical Content Editorial Policy
Was this page helpful?
We would love to help them too.
With a free 3-min Acute Glaucoma Attack quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms

Our AI

Your report

Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
See full list
Q.
At what age should you get tested for Glaucoma?
A.
Get a baseline glaucoma exam at age 40 if you are at average risk, then repeat every 1 to 4 years, with shorter intervals as you get older. There are several factors to consider, and people at higher risk may need to start earlier and be seen more often, including those with a parent or sibling with glaucoma, African, Hispanic or Asian heritage, prior high eye pressure, thin corneas, long-term steroid use, diabetes, or high blood pressure. See below for detailed risk criteria, age-based follow-up intervals, and what to expect during screening.
References:
Moyer VA; US Preventive Services Task Force. (2013). Screening for primary open-angle glaucoma: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med, 23460085.
https://pubmed.ncbi.nlm.nih.gov/23460085/
Mitchell P, Smith W, Attebo K, & Healey PR. (1996). Prevalence of open-angle glaucoma in Australia. Ophthalmology, 8916438.
https://pubmed.ncbi.nlm.nih.gov/8916438/
D’Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of Hepatology, 16678306.
Q.
Can you have Glaucoma even with good vision?
A.
Yes. Glaucoma can be present even with sharp central vision because it often starts by damaging peripheral vision and can occur at normal eye pressure. There are several factors to consider. See below for risk factors, recommended exam schedules and tests, early warning signs, and treatment options that could influence your next steps.
References:
Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda‐Jonas S. (2017). Glaucoma. Lancet, 28018717.
https://pubmed.ncbi.nlm.nih.gov/28018717/
Tsochatzis EA, Bosch J, Burroughs AK. (2014). Liver cirrhosis. Lancet, 24280774.
https://pubmed.ncbi.nlm.nih.gov/24280774/
Bissonnette J, Lapointe E, Ollivier L, et al. (2019). Identification of patients with compensated advanced chronic … J Hepatol, 31160431.
Q.
Can you have Glaucoma with normal eye pressure?
A.
Yes, glaucoma can occur with normal eye pressure, called normal-tension glaucoma, where the optic nerve is damaged and vision can be lost even when IOP is under 21 mm Hg. There are several factors to consider, including vascular issues, thin corneas, age or family history, and diagnosis and monitoring rely on specific tests, while treatment still focuses on lowering pressure by about 30 percent, so see below for key risks, warning signs, testing, and when to seek an ophthalmology exam.
References:
Collaborative Normal-Tension Glaucoma Study Group. (1998). The Collaborative Normal-Tension Glaucoma Study: design and… Ophthalmology, 9809487.
https://pubmed.ncbi.nlm.nih.gov/9809487/
Friedrich-Rust M, Ong MF, Martens S, et al. (2008). Liver stiffness measurement by transient elastography: a non-invasive… Journal of Hepatology, 18395273.
https://pubmed.ncbi.nlm.nih.gov/18395273/
Vallet-Pichard A, et al. (2007). FIB-4: a noninvasive index that predicts significant fibrosis in… Hepatology, 17321780.
Q.
Can you stop Glaucoma from getting worse?
A.
In many people, glaucoma can be slowed or even halted by lowering eye pressure with prescription eye drops, laser therapy, or surgery; while lost vision cannot be restored, early diagnosis and consistent follow up are key. There are several factors to consider, including your personalized target pressure, strict medication adherence, supportive lifestyle steps, and urgent symptoms that need immediate care; see the complete details below for guidance that could affect your next steps.
References:
Kass MA, Heuer DK, Higginbotham EJ, et al. (2002). The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents… Archives of Ophthalmology, 120(6):701-713. PMID:12004025.
https://pubmed.ncbi.nlm.nih.gov/12004025/
Collaborative Normal-Tension Glaucoma Study Group. (1998). The effectiveness of intraocular pressure reduction in normal-tension glaucoma… American Journal of Ophthalmology, 126(4):498-505. PMID:9777777.
https://pubmed.ncbi.nlm.nih.gov/9777777/
Wiesner R, Edwards E, Freeman R, et al. (2003). Model for end-stage liver disease (MELD) and allocation of donor livers… American Journal of Transplantation, 3(2):164-170. PMID:12423938.
Q.
Does Glaucoma always cause blindness?
A.
Glaucoma does not always cause blindness; with early detection and consistent treatment, most people maintain functional vision. Still, untreated or advanced glaucoma can lead to irreversible vision loss or legal blindness, and there are crucial factors and next steps to consider, so see below for risks, warning signs, screening schedules, and treatment options that can help protect your sight.
References:
Tham YC, Li X, Wong TY, Quigley HA, Aung T, & Cheng CY. (2014). Global prevalence of glaucoma and projections through 2040:… Ophthalmology, 25036642.
https://pubmed.ncbi.nlm.nih.gov/25036642/
Castera L, Forns X, & Alberti A. (2008). Non-invasive evaluation of liver fibrosis by transient elastography: a prospective comp… J Hepatol, 18280091.
https://pubmed.ncbi.nlm.nih.gov/18280091/
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, & Lok AS. (2003). A simple noninvasive index can predict both significant fibrosis … Hepatology, 12668963.
Q.
How to catch Glaucoma early?
A.
Early glaucoma screening means regular comprehensive eye exams beginning at 40, or sooner if you have risk factors like family history, certain ancestries, diabetes, high eye pressure, steroid use, or prior eye injury, using tonometry, optic nerve evaluation, visual field testing, and OCT, with intervals tailored to your risk. Watch for subtle changes in peripheral vision or halos and seek prompt care, as early treatment preserves sight; there are several factors to consider, so see the complete guidance below for who is high risk, how often to screen, what to expect at an exam, practical ways to access screening, and when symptoms require urgent care.
References:
Lin JS, Lohr KN, Becker LA, & Whitlock EP. (2013). Screening for open‐angle glaucoma in adults: U.S. Preventive Services… JAMA, 24098217.
https://pubmed.ncbi.nlm.nih.gov/24098217/
Prum BE, Rosenberg LF, Gedde SJ, Mansberger SL, Stein JD, Moroi SE, et al. (2016). Primary open‐angle glaucoma preferred practice pattern guidelines… Ophthalmology, 27409944.
https://pubmed.ncbi.nlm.nih.gov/27409944/
D’Amico G, Garcia‐Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis: a systematic… J Hepatol, 17062637.
Q.
Is Glaucoma curable or a lifelong condition?
A.
Glaucoma is not curable and is typically a lifelong condition; optic nerve damage cannot be reversed, but lowering eye pressure with drops, lasers, or surgery can slow progression and help preserve vision. There are several factors to consider, including early detection, strict treatment adherence, and your personal risk profile. See below for details on monitoring frequency, treatment options, lifestyle steps, and when to seek urgent care.
References:
Weinreb RN, Aung T, & Medeiros FA. (2014). The pathophysiology and treatment of glaucoma: A review. JAMA, 25224363.
https://pubmed.ncbi.nlm.nih.gov/25224363/
Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, & Cheng CY. (2014). Global prevalence of glaucoma and projections of glaucoma burden… Ophthalmology, 24687098.
https://pubmed.ncbi.nlm.nih.gov/24687098/
D'Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis: a systematic… Journal of Hepatology, 16581114.
Q.
Is nearsightedness linked to Glaucoma?
A.
Yes: nearsightedness is linked to a higher risk of glaucoma, especially primary open-angle glaucoma, and the risk rises with severity (about 1.7x for low myopia, ~2.5x for moderate, ~3.3x for high). There are several factors to consider. See below for why myopic eye structure increases vulnerability and can hide early disease, the key warning signs, and the recommended exam schedule and treatment options that could shape your next steps.
References:
Chen X, Wang Y, Zhong X, et al. (2019). Refractive error and risk of open-angle glaucoma: a meta-analysis of observational… Ophthalmology, 31451760.
https://pubmed.ncbi.nlm.nih.gov/31451760/
Lin L, Song W, Liu K. (2018). Axial length, peripapillary retinal nerve fiber layer thickness, and the risk of primary open-angle… Invest Ophthalmol Vis Sci, 30197803.
https://pubmed.ncbi.nlm.nih.gov/30197803/
Marasco G, Tsochatzis E, Meyer T. (2015). Liver stiffness measurement predicts disease progression in patients with compensated… Journal of Hepatology, 25707701.
Q.
What are the early symptoms of Glaucoma?
A.
Early symptoms of glaucoma can be subtle, such as patchy blind spots and gradual loss of side vision, halos around lights, slow adaptation to darkness, occasional blurred vision, mild eye aching or brow headaches, and sometimes eye redness. Because many people have no early symptoms at all, your risk factors and the need for timely eye exams are crucial to next steps; there are several factors to consider, so see the complete details below.
References:
Weinreb RN, & Khaw PT. (2004). Primary open-angle glaucoma. Lancet, 15158671.
https://pubmed.ncbi.nlm.nih.gov/15158671/
Kass MA, & Heuer DK. (2002). The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol, 12003421.
https://pubmed.ncbi.nlm.nih.gov/12003421/
European Association for the Study of the Liver. (2018). EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology, 29443864.
Q.
What is your Glaucoma risk if you have a family history?
A.
If you have a parent, sibling, or child with primary open-angle glaucoma, your risk is about 3 to 4 times higher than average; siblings may face up to around a 10 percent lifetime risk versus about 2 to 3 percent in the general population. There are several factors to consider. See below to understand how age, eye pressure, corneal thickness, optic nerve appearance, and race influence your individual risk and to review screening recommendations and next steps.
References:
Ocular Hypertension Treatment Study Group. (2002). Baseline factors that predict the onset of primary open-angle… Arch Ophthalmol, 12049517.
https://pubmed.ncbi.nlm.nih.gov/12049517/
Wolfs RC, Klaver CC, Gedde SJ, Hofman A, & de Jong PTVM. (1996). Familial aggregation of primary open-angle glaucoma:… Arch Ophthalmol, 8646376.
https://pubmed.ncbi.nlm.nih.gov/8646376/
Kamath PS, & Wiesner RH. (2001). A model to predict survival in patients with end-stage liver disease… Hepatology, 11157951.
Q.
Why early detection of Glaucoma important?
A.
Early detection of glaucoma is crucial because it often has no early symptoms yet can cause irreversible vision loss; catching it early lets your eye doctor lower eye pressure, slow progression by up to 50 percent, preserve vision and independence, and may reduce treatment burden and costs. There are several factors to consider, from personal risk and screening timing to the most useful tests and treatments; see the full guidance below to decide your next steps, including when to book a comprehensive eye exam.
References:
Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. (2002). Reduction of intraocular pressure and glaucoma progression: … Arch Ophthalmol, 12426501.
https://pubmed.ncbi.nlm.nih.gov/12426501/
Zhang Y, Peng MB, Wu ZR, et al. (2017). Diagnostic performance of optical coherence tomography for … American Journal of Ophthalmology, 28667453.
https://pubmed.ncbi.nlm.nih.gov/28667453/
D’Amico G, Garcia‐Tsao G, Pagliaro L. (2006). Natural history and prognostic indicators of survival in cir… Journal of Hepatology, 16325446.
Q.
Why eye drops are used to treat Glaucoma?
A.
Eye drops are used because they directly lower intraocular pressure by either reducing the eye’s fluid production or increasing its drainage, which protects the optic nerve and slows or prevents vision loss; they are the first-line treatment since they are effective, targeted, and easy to use at home. There are several factors to consider, including which drug class is best, proper drop technique, adherence, side effects, and when laser or surgery might be needed; see below for details that can guide your next steps and follow-up care.
References:
Lee DA, & Higginbotham EJ. (2005). Glaucoma and its treatment: a review. Am J Health Syst Pharm, 15722430.
https://pubmed.ncbi.nlm.nih.gov/15722430/
McKinnon SJ, Goldberg I, & Pelzuf O. (2011). Medical management of glaucoma: current status and future… Clin Ophthalmol, 21873338.
https://pubmed.ncbi.nlm.nih.gov/21873338/
Wang C, Zeng J, & Li L. (2012). Transient elastography in the diagnosis of advanced liver fibros… J Viral Hepat, 21723551.
Q.
Why Glaucoma progresses without notice?
A.
It often advances quietly because early damage targets peripheral vision while central sight stays sharp, the brain fills in missing areas, and there is usually no pain; optic nerve injury can continue from fluctuating or even normal eye pressure. There are several factors to consider, including age, family history, eye-to-eye differences, and missed drops or visits; see below for warning signs, when to get screened, and the next steps that could change your care plan.
References:
Leske MC, Heijl A, Hyman L, Bengtsson B, Dong LS, Yang Z. (2003). Reduction of intraocular pressure and glaucoma progression: results from the early… Arch Ophthalmol, 12523815.
https://pubmed.ncbi.nlm.nih.gov/12523815/
Weinreb RN, Khaw PT. (2004). Primary open-angle glaucoma. Lancet, 15158652.
https://pubmed.ncbi.nlm.nih.gov/15158652/
Tsochatzis EA, Bosch J, Burroughs AK. (2014). Liver cirrhosis. Lancet, 24581656.
Q.
Why is Glaucoma called the "Silent Thief of Sight"?
A.
Glaucoma is called the silent thief of sight because it causes progressive, irreversible damage to the optic nerve that usually starts without pain or early warning, gradually stealing peripheral vision before noticeable changes occur. There are several factors to consider, including who is at higher risk, how to catch it early with routine eye exams, and which symptoms require urgent care; see below for key tests, treatment options, and the right next steps.
References:
Weinreb RN, Aung T, & Medeiros FA. (2014). The pathophysiology and treatment of glaucoma: a review. Survey of Ophthalmology, 24698399.
https://pubmed.ncbi.nlm.nih.gov/24698399/
D’Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cir… Journal of Hepatology, 16440493.
https://pubmed.ncbi.nlm.nih.gov/16440493/
Kamath PS, & Wiesner RH. (2001). A model to predict survival in patients with end-stage liver… Hepatology, 11157951.
Q.
Can Glaucoma affect only one eye?
A.
Yes. Glaucoma can affect just one eye at first, and some secondary types or an acute angle-closure attack can be truly confined to one eye, but most forms put both eyes at risk and often start asymmetrically. Important details on which types behave this way, red-flag symptoms, how it is diagnosed, and treatments to protect the other eye are explained below so you can plan the right next steps.
References:
Weinreb RN, & Khaw PT. (2004). Primary open‐angle glaucoma. Lancet, 15158654.
https://pubmed.ncbi.nlm.nih.gov/15158654/
Foster PJ, & Johnson GJ. (2001). Mechanisms of disease: primary angle‐closure glaucoma. Lancet, 11378005.
https://pubmed.ncbi.nlm.nih.gov/11378005/
D'Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis: a systematic… Journal of Hepatology, 16332530.
Q.
Can routine eye exams detect Glaucoma?
A.
Yes. Comprehensive routine eye exams can detect glaucoma early by measuring eye pressure, examining the optic nerve, and checking visual fields, often before symptoms appear; advanced imaging like OCT may also be used, but no single test confirms it alone. There are several factors to consider, including age and family risk, how often to be screened, limitations like normal tension glaucoma, and urgent symptoms that need immediate care. See below for the complete answer and next steps to protect your vision.
References:
Heijl A, Leske MC, & Bengtsson B. (2003). Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial… Arch Ophthalmol, 12670942.
https://pubmed.ncbi.nlm.nih.gov/12670942/
Coleman AL, & Miglior S. (2008). Risk factors for glaucoma onset and progression… Surv Ophthalmol, 19054729.
https://pubmed.ncbi.nlm.nih.gov/19054729/
Wlodzimirow KA, Euwema MD, & Abu‐Hanna A. (2013). The prognostic performance of MELD and Child–Pugh in predicting mortality in cirrhosis: a systematic review… Ann Hepatol, 23518043.
Q.
Can young people get Glaucoma?
A.
Yes, young people can get glaucoma, including juvenile open-angle, congenital, and secondary types, and it can permanently damage vision if not treated early. Family history, certain genes, eye injuries, and long-term steroid use raise risk, and because early glaucoma is often symptom free, regular eye exams and prompt treatment matter; there are several factors to consider, see below for warning signs, tests, and the best next steps.
References:
Carney LG, & Hitchings RA. (1987). Clinical features of juvenile glaucoma… Ophthalmology, 3354809.
https://pubmed.ncbi.nlm.nih.gov/3354809/
Kwon YH, Fingert JH, Kuehn MH, & Alward WL. (2009). Primary open‐angle glaucoma… N Engl J Med, 19297566.
https://pubmed.ncbi.nlm.nih.gov/19297566/
Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, & Burroughs AK. (2011). Elastography for the diagnosis of… Clin Gastroenterol Hepatol, 20494256.
Q.
How Glaucoma leads to vision loss?
A.
Glaucoma causes vision loss when fluid buildup raises intraocular pressure and reduces blood flow, damaging the optic nerve and killing retinal ganglion cells; this typically begins with peripheral vision loss and can become permanent if untreated. There are several factors to consider, including the type of glaucoma, your risk factors, early warning signs, and treatments that can slow or prevent further damage. See below for the complete answer with details that could guide your next steps and when to seek care.
References:
Weinreb RN, Aung T, & Medeiros FA. (2014). The pathophysiology and treatment of glaucoma: a review. JAMA, 24825645.
https://pubmed.ncbi.nlm.nih.gov/24825645/
Nickells RW, Howell GR, Soto I, & John SW. (2012). Under pressure: cellular and molecular responses during glau… Annu Rev Neurosci, 22402607.
https://pubmed.ncbi.nlm.nih.gov/22402607/
D'Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrh… J Hepatol, 16385108.
Q.
How is Glaucoma detected without symptoms?
A.
Glaucoma without symptoms is detected during a comprehensive eye exam that combines intraocular pressure measurement, optic nerve evaluation, OCT imaging to measure retinal nerve fiber thickness, and visual field testing, often refined by pachymetry and gonioscopy; no single test is definitive, so doctors synthesize results. Because damage can occur before any vision changes, routine screening is advised, especially if you are over 40 or have risk factors like family history or high myopia; there are several factors to consider, and important details that can affect your next steps are explained below.
References:
Parisi V, Restuccia R, Fattapposta F, Zito G, Valente D, Buonavoglia A, Buxton DF. (1999). Retinal nerve fiber layer thickness measured by optical coherence… Invest Ophthalmol Vis Sci, 10488950.
https://pubmed.ncbi.nlm.nih.gov/10488950/
European Association for the Study of the Liver. (2018). EASL clinical practice guidelines for the management of patients… Journal of Hepatology, 30189588.
https://pubmed.ncbi.nlm.nih.gov/30189588/
Seo YS, Kim SU, Kim DY, Ahn SH, Han KH. (2017). Liver stiffness measurement predicts risk of decompensation, hepatocellular… Clin Gastroenterol Hepatol, 27663728.
Q.
Is Glaucoma testing painful?
A.
Most glaucoma tests are not painful; they are quick and designed for comfort, with air-puff or rebound measurements feeling like a brief tap and contact tests made comfortable with numbing drops. There are several factors to consider about what each test feels like, normal mild irritation afterward, options if you have anxiety, and red flags like severe pain or sudden vision changes that need prompt care. See below for complete details and next steps.
References:
Martinez‐de‐la‐Casa JM, García‐Feijoo J, Castillo A, de la Rosa EG, Rebolleda G, Muñoz‐Negrete FJ. (2010). Comparison of the iCare rebound tonometer and the Goldmann applanation tonometer in normal eyes. Clinical & Experimental Ophthalmology, 20406972.
https://pubmed.ncbi.nlm.nih.gov/20406972/
Kamath PS, & Wiesner RH. (2001). A model to predict survival in patients with end-stage liver disease. Hepatology, 11157951.
https://pubmed.ncbi.nlm.nih.gov/11157951/
European Association for the Study of the Liver. (2014). EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology, 24986678.
Q.
What does vision loss from Glaucoma look like?
A.
Vision loss from glaucoma usually begins with subtle peripheral blind spots that are easy to miss, progresses to a narrowing of the visual field that feels like tunnel vision, and can ultimately affect central vision and lead to permanent blindness if not treated. There are several factors to consider; see below for details on the stages of vision loss, real-life warning signs, urgent symptoms, and the specific tests and treatments that can help protect your sight and guide next steps.
References:
Heijl A, Leske MC, Bengtsson B, et al. (2002). Reduction of intraocular pressure and glaucoma progression:… Arch Ophthalmol, 12018687.
https://pubmed.ncbi.nlm.nih.gov/12018687/
Sandrin L, Fourquet B, Hasquenoph JM, et al. (2003). Transient elastography: a new noninvasive method for assessme… Ultrasound Med Biol, 12821203.
https://pubmed.ncbi.nlm.nih.gov/12821203/
Wai CT, Greenson JK, Fontana RJ, et al. (2003). A simple noninvasive index can predict both significant… Hepatology, 12746922.
Q.
What happens during a Glaucoma eye exam?
A.
A glaucoma eye exam is a painless, comprehensive visit that typically includes history and vision checks, eye pressure measurement, corneal thickness testing, drainage angle evaluation, optic nerve assessment, visual field testing, and OCT imaging. Your doctor then explains your risk or diagnosis and recommends monitoring, eye drops, laser, or surgery as needed, but there are important details that can affect your next steps; see the complete breakdown below.
References:
Kim JM, Park KH, & Kim H. (2005). Comparative analysis of standard automated perimetry and frequen… Ophthalmology, 15783114.
https://pubmed.ncbi.nlm.nih.gov/15783114/
Mwanza JC, Oakley JD, Budenz DL, Chang RT, Knight OJ, & Feuer WJ. (2012). Diagnostic performance of spectral-domain optical coherence tomogr… Ophthalmology, 20926890.
https://pubmed.ncbi.nlm.nih.gov/20926890/
Friedrich-Rust G, Ong M-F, Martens S, et al. (2008). Performance of transient elastography for the staging of live… Gastroenterology, 19033822.
Q.
What happens if Glaucoma is left untreated?
A.
Left untreated, glaucoma causes irreversible optic nerve damage and progressive vision loss, usually beginning with peripheral vision, advancing to tunnel vision, and potentially ending in blindness. There are several factors to consider, and timely treatment that lowers eye pressure has been proven to slow progression; risks to safety, independence, and daily tasks are explained in detail. See below for key details and practical next steps for your care.
References:
Collaborative Normal-Tension Glaucoma Study Group. (1998). The effectiveness of intraocular pressure reduction in the management of normal-tension glauco… American Journal of Ophthalmology, 9590417.
https://pubmed.ncbi.nlm.nih.gov/9590417/
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; EMGT Group. (2003). Factors for glaucoma progression and the effect of treatment: the Early Manifest… Archives of Ophthalmology, 14662591.
https://pubmed.ncbi.nlm.nih.gov/14662591/
D’Amico G, Garcia-Tsao G, Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis: a systematic review o… Journal of Hepatology, 16427282.
Q.
What to do after being diagnosed with Glaucoma?
A.
Confirm your glaucoma type and stage and your target eye pressure with your eye doctor, then follow a personalized plan that may include prescription drops, laser like SLT, or surgery, with regular pressure checks, visual field tests, and OCT imaging. Use reminders to take drops correctly, make supportive lifestyle changes, involve family, and know urgent warning signs such as sudden severe eye pain, halos, or vision loss that need immediate care. There are several factors to consider, and the specifics can change your next steps. See the complete details below for monitoring timelines, drop techniques, when to seek a second opinion, mental health and low vision resources, and what to do in emergencies.
References:
Jampel HD, Schwartz GF, Liebmann JM, Kang J, Lin SC, Malihi M, & Folberg R. (2012). Primary open-angle glaucoma preferred practice pattern®. Ophthalmology, 22033160.
https://pubmed.ncbi.nlm.nih.gov/22033160/
Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, & Hussein M. (2002). Reduction of intraocular pressure and glaucoma progression: results… Arch Ophthalmol, 12365901.
https://pubmed.ncbi.nlm.nih.gov/12365901/
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, & Kosberg CL. (2001). A model to predict survival in patients with end-stage liver disease. Hepatology, 11157951.
Q.
What's most important in Glaucoma treatment?
A.
Lowering intraocular pressure is the cornerstone of glaucoma treatment, and combining it with early detection and regular monitoring is what most effectively preserves vision. Because the right plan depends on your personal risk factors, target pressure, and consistent use of therapies, there are several factors to consider; see below for the key details that could shape your next steps.
References:
Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Mills RP, et al. (2002). The Ocular Hypertension Treatment Study: baseline factors that predict… Arch Ophthalmol, 12070400.
https://pubmed.ncbi.nlm.nih.gov/12070400/
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, et al. (2003). Factors for glaucoma progression and the effect of treatment: the Early… Arch Ophthalmol, 12578531.
https://pubmed.ncbi.nlm.nih.gov/12578531/
European Association for the Study of the Liver. (2018). EASL Clinical Practice Guidelines for the management of patients with… Journal of Hepatology, 29903232.
Q.
What's the difference between Glaucoma and Cataracts?
A.
There are key differences to consider: cataracts cloud the eye’s lens, causing blurry, glare-prone vision that is usually reversible with surgery, while glaucoma damages the optic nerve, often from high eye pressure, leading to irreversible vision loss managed with drops, laser or surgery. Because glaucoma can be silent early and angle-closure can be an emergency with sudden eye pain, halos, redness, nausea and vomiting, important next steps depend on these nuances. See the complete details below for symptoms, tests, treatment choices, prevention and when to seek urgent care.
References:
Hashemi H, Mohammad Zadeh H, Khabazkhoob M, Yekta A, Fotouhi A. (2014). Global and regional prevalence of cortical, nuclear and posterior… J Ophthalmic Vis Res, 25590066.
https://pubmed.ncbi.nlm.nih.gov/25590066/
Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. (2014). Global prevalence of glaucoma and projections of glaucoma burden… Ophthalmology, 24974815.
https://pubmed.ncbi.nlm.nih.gov/24974815/
European Association for the Study of the Liver. (2018). EASL clinical practice guidelines on decompensated cirrhosis. Journal of Hepatology, 29702081.
Q.
When is surgery needed for Glaucoma instead of eye drops?
A.
Surgery is generally recommended when eye pressure stays above your target despite maximum tolerated drops, if vision or optic nerve damage progresses, if drops cause significant side effects or are hard to use consistently, or in advanced or secondary glaucomas. There are several factors to consider, and options range from in-office lasers to minimally invasive or filtering surgeries, with the choice guided by how low your pressure needs to be and your risk profile; see below for important details that can affect the best next step in your care.
References:
Gordon MO, Beiser JA, Brandt JD, et al. (2005). Five-year outcomes of medical versus surgical therapy for newly diagn… Ophthalmology, 15790964.
https://pubmed.ncbi.nlm.nih.gov/15790964/
European Glaucoma Society. (2014). Terminology and guidelines for glaucoma, 4th edition – Part 1. Br J Ophthalmol, 24691324.
https://pubmed.ncbi.nlm.nih.gov/24691324/
European Association for the Study of the Liver. (2017). EASL–ALEH Clinical Practice Guidelines for non-invasive tests in evaluati… J Hepatol, 28936804.
Q.
Who is at higher risk for Glaucoma?
A.
People at higher risk include adults over 60, those with a first-degree family history, people of African or Afro-Caribbean descent, Hispanic/Latino adults especially after 70, individuals of Asian descent for angle-closure, and anyone with elevated eye pressure or thin corneas. Other contributors include diabetes, hypertension, migraines or vasospastic disorders, severe myopia, sleep apnea, eye injuries, long-term steroid use, and uveitis. There are several factors to consider, and the full list plus symptoms, screening schedules, and when to seek urgent care can change your next steps; see below for the complete answer.
References:
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, & Komaroff E. (2001). Risk factors for open-angle glaucoma: the Barbados Eye Study. Arch Ophthalmol, 11709092.
https://pubmed.ncbi.nlm.nih.gov/11709092/
D'Amico G, Garcia-Tsao G, & Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis:... Gastroenterology, 16447235.
https://pubmed.ncbi.nlm.nih.gov/16447235/
Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, & Burroughs AK. (2011). Elastography for the diagnosis of severity of fibrosis in chronic... J Hepatol, 21371546.
Q.
Why ongoing treatment for Glaucoma is important?
A.
Ongoing care is vital because only consistent lowering of eye pressure through drops, laser, or surgery slows irreversible optic nerve damage, preserving vision and reducing the risk of blindness. Regular monitoring and strong adherence matter, since pressure spikes from missed meds or appointments can speed progression; there are several factors to consider, and important next steps may depend on them, so see below to understand more.
References:
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO. (2002). Topical ocular hypotensive medication delays or prevents onset… JAMA, 12155417.
https://pubmed.ncbi.nlm.nih.gov/12155417/
Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M. (2002). Reduction of intraocular pressure and glaucoma progression… Arch Ophthalmol, 12456851.
https://pubmed.ncbi.nlm.nih.gov/12456851/
D'Amico G, Garcia-Tsao G, Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis… Journal of Hepatology, 16310454.
Q.
Why you need Glaucoma Screening even without symptoms?
A.
Glaucoma can silently and permanently damage vision without pain or early warning, so screening is crucial even when your eyes feel normal. Detecting high eye pressure and optic nerve changes early allows timely treatment that can reduce risk and slow progression. There are several factors to consider, including age, family history, and race, plus how often you should be screened and what tests are used. See below for the complete guidance and next steps that could influence when to schedule an exam and when to seek urgent care.
References:
Kass MA, Heuer DK, & Higginbotham EJ. (2002). The Ocular Hypertension Treatment Study: baseline factors that… Archives of Ophthalmology, 12479574.
https://pubmed.ncbi.nlm.nih.gov/12479574/
Heijl A, Leske MC, & Bengtsson B. (2002). Reduction of intraocular pressure and glaucoma progression: resu… Archives of Ophthalmology, 10432868.
https://pubmed.ncbi.nlm.nih.gov/10432868/
Malinchoc M, Kamath PS, & Gordon FD. (2000). A model to predict poor survival in patients undergoing transjug… Hepatology, 10733522.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

“World’s Best Digital
Health Companies”
Newsweek 2024

“Best With AI”
Google Play Best of 2023

“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1Flores-Sánchez BC, Tatham AJ (2019). Acute angle closure glaucoma. British journal of hospital medicine (London, England : 2005).
https://pubmed.ncbi.nlm.nih.gov/31822188/Chan PP, Pang JC, Tham CC (2018). Acute primary angle closure-treatment strategies, evidences and economical considerations. Eye (London, England).
https://pubmed.ncbi.nlm.nih.gov/30467424/Lachkar Y, Bouassida W (2007). Drug-induced acute angle closure glaucoma. Current opinion in ophthalmology.
https://pubmed.ncbi.nlm.nih.gov/17301614/